Theratechnologies, Inc. (THTX)
3.39
0.00 (0.00%)
USD |
NASDAQ |
Jan 16, 16:00
Theratechnologies EPS Diluted (Quarterly): -0.0904 for May 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Achieve Life Sciences, Inc. | -0.2831 |
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.3157 |
| Lexaria Bioscience Corp. | -0.0746 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.462M |
| Revenue (Quarterly) | 17.73M |
| Total Expenses (Quarterly) | 22.19M |
| Enterprise Value | 189.57M |
| Gross Profit Margin (Quarterly) | 72.86% |
| Profit Margin (Quarterly) | -25.17% |
| Earnings Yield | -5.82% |
| Operating Earnings Yield | 3.28% |
| Normalized Earnings Yield | -2.513 |